Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Characteristics associated with informed consent for genetic studies in the ACCORD trial.

Simons-Morton DG, Chan JC, Kimel AR, Linz PE, Stowe CL, Summerson J, Ambrosius WT.

Contemp Clin Trials. 2014 Jan;37(1):155-64. doi: 10.1016/j.cct.2013.12.002. Epub 2013 Dec 17.

2.

Can primary care physician-driven community programs address the obesity epidemic among high-risk populations?

Benjamin RM, Yanovski SZ, Simons-Morton DG.

JAMA Intern Med. 2013 Oct 28;173(19):1778-9. doi: 10.1001/jamainternmed.2013.7776. No abstract available.

PMID:
23979565
3.

Effects of combination lipid therapy in type 2 diabetes mellitus.

ACCORD Study Group, Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP.

N Engl J Med. 2010 Apr 29;362(17):1563-74. doi: 10.1056/NEJMoa1001282. Epub 2010 Mar 14. Erratum in: N Engl J Med. 2010 May 6;362(18):1748.

4.

Effects of intensive blood-pressure control in type 2 diabetes mellitus.

ACCORD Study Group, Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F.

N Engl J Med. 2010 Apr 29;362(17):1575-85. doi: 10.1056/NEJMoa1001286. Epub 2010 Mar 14.

5.

Obesity research and programs at the National Heart, Lung, and Blood Institute.

Simons-Morton DG, Donato K, Loria CM, Pratt CA, Ershow AG, Morrissette MA, Czajkowski S, Arteaga SS, Obarzanek E.

J Am Coll Cardiol. 2010 Mar 2;55(9):917-20. doi: 10.1016/j.jacc.2009.09.058. Review. No abstract available.

6.

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Calles-Escandón J, Lovato LC, Simons-Morton DG, Kendall DM, Pop-Busui R, Cohen RM, Bonds DE, Fonseca VA, Ismail-Beigi F, Banerji MA, Failor A, Hamilton B.

Diabetes Care. 2010 Apr;33(4):721-7. doi: 10.2337/dc09-1471. Epub 2010 Jan 26.

8.

The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop.

Khoury MJ, McBride CM, Schully SD, Ioannidis JP, Feero WG, Janssens AC, Gwinn M, Simons-Morton DG, Bernhardt JM, Cargill M, Chanock SJ, Church GM, Coates RJ, Collins FS, Croyle RT, Davis BR, Downing GJ, Duross A, Friedman S, Gail MH, Ginsburg GS, Green RC, Greene MH, Greenland P, Gulcher JR, Hsu A, Hudson KL, Kardia SL, Kimmel PL, Lauer MS, Miller AM, Offit K, Ransohoff DF, Roberts JS, Rasooly RS, Stefansson K, Terry SF, Teutsch SM, Trepanier A, Wanke KL, Witte JS, Xu J; Centers for Disease Control and Prevention.

Genet Med. 2009 Aug;11(8):559-67. doi: 10.1097/GIM.0b013e3181b13a6c.

9.

The glycemia-cardiovascular disease hypothesis.

Simons-Morton DG.

Clin Transl Sci. 2008 Dec;1(3):185-6. doi: 10.1111/j.1752-8062.2008.00065.x. No abstract available.

10.

Effects of intensive glucose lowering in type 2 diabetes.

Action to Control Cardiovascular Risk in Diabetes Study Group, Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT.

N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.

11.

Severe hypoglycemia monitoring and risk management procedures in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Bonds DE, Kurashige EM, Bergenstal R, Brillon D, Domanski M, Felicetta JV, Fonseca VA, Hall K, Hramiak I, Miller ME, Osei K, Simons-Morton DG; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):80i-89i. Epub 2007 Apr 17.

PMID:
17599428
12.

Prevention of cardiovascular disease in persons with type 2 diabetes mellitus: current knowledge and rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.

Goff DC Jr, Gerstein HC, Ginsberg HN, Cushman WC, Margolis KL, Byington RP, Buse JB, Genuth S, Probstfield JL, Simons-Morton DG; ACCORD Study Group.

Am J Cardiol. 2007 Jun 18;99(12A):4i-20i. Epub 2007 Apr 12. Review.

PMID:
17599424
13.

Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods.

ACCORD Study Group, Buse JB, Bigger JT, Byington RP, Cooper LS, Cushman WC, Friedewald WT, Genuth S, Gerstein HC, Ginsberg HN, Goff DC Jr, Grimm RH Jr, Margolis KL, Probstfield JL, Simons-Morton DG, Sullivan MD.

Am J Cardiol. 2007 Jun 18;99(12A):21i-33i. Epub 2007 Apr 16.

PMID:
17599422
14.

Data and safety monitoring of rosiglitazone trials.

Nabel EG, Shurin SB, Simons-Morton DG, Gordon D.

Lancet. 2007 Jun 23;369(9579):2077. No abstract available.

PMID:
17586301
15.

Effects of individual components of multiple behavior changes: the PREMIER trial.

Obarzanek E, Vollmer WM, Lin PH, Cooper LS, Young DR, Ard JD, Stevens VJ, Simons-Morton DG, Svetkey LP, Harsha DW, Elmer PJ, Appel LJ.

Am J Health Behav. 2007 Sep-Oct;31(5):545-60.

PMID:
17555385
16.

Higher self-reported physical activity is associated with lower systolic blood pressure: the Dietary Intervention Study in Childhood (DISC).

Gidding SS, Barton BA, Dorgan JA, Kimm SY, Kwiterovich PO, Lasser NL, Robson AM, Stevens VJ, Van Horn L, Simons-Morton DG.

Pediatrics. 2006 Dec;118(6):2388-93.

PMID:
17142523
17.

PREMIER--a trial of lifestyle interventions for blood pressure control: intervention design and rationale.

Funk KL, Elmer PJ, Stevens VJ, Harsha DW, Craddick SR, Lin PH, Young DR, Champagne CM, Brantley PJ, McCarron PB, Simons-Morton DG, Appel LJ.

Health Promot Pract. 2008 Jul;9(3):271-80. Epub 2006 Jun 27.

PMID:
16803935
18.

Obesity research--limitations of methods, measurements, and medications.

Simons-Morton DG, Obarzanek E, Cutler JA.

JAMA. 2006 Feb 15;295(7):826-8. No abstract available.

PMID:
16478906
19.

Design of the Trial of Activity in Adolescent Girls (TAAG).

Stevens J, Murray DM, Catellier DJ, Hannan PJ, Lytle LA, Elder JP, Young DR, Simons-Morton DG, Webber LS.

Contemp Clin Trials. 2005 Apr;26(2):223-33.

20.

The burden of treatment failure in type 2 diabetes: response to Brown et al.

Simons-Morton DG, Genuth S, Byington RP, Gerstein HC, Friedewald WT.

Diabetes Care. 2005 Mar;28(3):761-2. No abstract available.

PMID:
15735233
21.

Effect of the dietary approaches to stop hypertension diet and reduced sodium intake on blood pressure control.

Svetkey LP, Simons-Morton DG, Proschan MA, Sacks FM, Conlin PR, Harsha D, Moore TJ.

J Clin Hypertens (Greenwich). 2004 Jul;6(7):373-81.

22.

Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics.

Svetkey LP, Harsha DW, Vollmer WM, Stevens VJ, Obarzanek E, Elmer PJ, Lin PH, Champagne C, Simons-Morton DG, Aickin M, Proschan MA, Appel LJ.

Ann Epidemiol. 2003 Jul;13(6):462-71.

PMID:
12875806
23.

Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial.

Vollmer WM, Sacks FM, Ard J, Appel LJ, Bray GA, Simons-Morton DG, Conlin PR, Svetkey LP, Erlinger TP, Moore TJ, Karanja N; DASH-Sodium Trial Collaborative Research Group.

Ann Intern Med. 2001 Dec 18;135(12):1019-28.

PMID:
11747380
24.

Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study.

Svetkey LP, Moore TJ, Simons-Morton DG, Appel LJ, Bray GA, Sacks FM, Ard JD, Mortensen RM, Mitchell SR, Conlin PR, Kesari M; DASH collaborative research group.

J Hypertens. 2001 Nov;19(11):1949-56.

PMID:
11677359
25.

Long-term safety and efficacy of a cholesterol-lowering diet in children with elevated low-density lipoprotein cholesterol: seven-year results of the Dietary Intervention Study in Children (DISC).

Obarzanek E, Kimm SY, Barton BA, Van Horn L L, Kwiterovich PO Jr, Simons-Morton DG, Hunsberger SA, Lasser NL, Robson AM, Franklin FA Jr, Lauer RM, Stevens VJ, Friedman LA, Dorgan JF, Greenlick MR; DISC Collaborative Research Group.

Pediatrics. 2001 Feb;107(2):256-64.

PMID:
11158455
26.

Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH; DASH-Sodium Collaborative Research Group.

N Engl J Med. 2001 Jan 4;344(1):3-10.

27.

Characteristics of inactive primary care patients: baseline data from the activity counseling trial. For the Activity Counseling Trial Research Group.

Simons-Morton DG, Hogan P, Dunn AL, Pruitt L, King AC, Levine BD, Miller ST.

Prev Med. 2000 Nov;31(5):513-21.

PMID:
11071831
28.

Efficacy and safety of lowering dietary intake of total fat, saturated fat, and cholesterol in children with elevated LDL cholesterol: the Dietary Intervention Study in Children.

Lauer RM, Obarzanek E, Hunsberger SA, Van Horn L, Hartmuller VW, Barton BA, Stevens VJ, Kwiterovich PO Jr, Franklin FA Jr, Kimm SY, Lasser NL, Simons-Morton DG.

Am J Clin Nutr. 2000 Nov;72(5 Suppl):1332S-1342S. doi: 10.1093/ajcn/72.5.1332s.

PMID:
11063475
29.

Impact of community intervention to reduce patient delay time on use of reperfusion therapy for acute myocardial infarction: rapid early action for coronary treatment (REACT) trial. REACT Study Group.

Hedges JR, Feldman HA, Bittner V, Goldberg RJ, Zapka J, Osganian SK, Murray DM, Simons-Morton DG, Linares A, Williams J, Luepker RV, Eisenberg MS.

Acad Emerg Med. 2000 Aug;7(8):862-72.

30.

Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) Trial.

Luepker RV, Raczynski JM, Osganian S, Goldberg RJ, Finnegan JR Jr, Hedges JR, Goff DC Jr, Eisenberg MS, Zapka JG, Feldman HA, Labarthe DR, McGovern PG, Cornell CE, Proschan MA, Simons-Morton DG.

JAMA. 2000 Jul 5;284(1):60-7.

PMID:
10872014
31.

Incorporating physical activity advice into primary care: physician-delivered advice within the activity counseling trial.

Albright CL, Cohen S, Gibbons L, Miller S, Marcus B, Sallis J, Imai K, Jernick J, Simons-Morton DG.

Am J Prev Med. 2000 Apr;18(3):225-34.

PMID:
10722989
32.

Missed opportunities to impact fast response to AMI symptoms.

Zapka JG, Oakes JM, Simons-Morton DG, Mann NC, Goldberg R, Sellers DE, Estabrook B, Gilliland J, Linares AC, Benjamin-Garner R, McGovern P.

Patient Educ Couns. 2000 Apr;40(1):67-82.

PMID:
10705066
33.

Prehospital delay in patients hospitalized with heart attack symptoms in the United States: the REACT trial. Rapid Early Action for Coronary Treatment (REACT) Study Group.

Goff DC Jr, Feldman HA, McGovern PG, Goldberg RJ, Simons-Morton DG, Cornell CE, Osganian SK, Cooper LS, Hedges JR.

Am Heart J. 1999 Dec;138(6 Pt 1):1046-57.

PMID:
10577434
34.

Effect of dietary patterns on ambulatory blood pressure : results from the Dietary Approaches to Stop Hypertension (DASH) Trial. DASH Collaborative Research Group.

Moore TJ, Vollmer WM, Appel LJ, Sacks FM, Svetkey LP, Vogt TM, Conlin PR, Simons-Morton DG, Carter-Edwards L, Harsha DW.

Hypertension. 1999 Sep;34(3):472-7.

PMID:
10489396
35.

Effects of interventions in health care settings on physical activity or cardiorespiratory fitness.

Simons-Morton DG, Calfas KJ, Oldenburg B, Burton NW.

Am J Prev Med. 1998 Nov;15(4):413-30. Review.

PMID:
9838981
36.

Rapid early action for coronary treatment: rationale, design, and baseline characteristics. REACT Research Group.

Simons-Morton DG, Goff DC, Osganian S, Goldberg RJ, Raczynski JM, Finnegan JR, Zapka J, Eisenberg MS, Proschan MA, Feldman HA, Hedges JR, Luepker RV.

Acad Emerg Med. 1998 Jul;5(7):726-38.

37.

Activity Counseling Trial (ACT): rationale, design, and methods. Activity Counseling Trial Research Group.

Blair SN, Applegate WB, Dunn AL, Ettinger WH, Haskell WL, King AC, Morgan TM, Shih JA, Simons-Morton DG.

Med Sci Sports Exerc. 1998 Jul;30(7):1097-106.

PMID:
9662679
38.

Overview of the Activity Counseling Trial (ACT) intervention for promoting physical activity in primary health care settings. Activity Counseling Trial Research Group.

King AC, Sallis JF, Dunn AL, Simons-Morton DG, Albright CA, Cohen S, Rejeski WJ, Marcus BH, Coday MC.

Med Sci Sports Exerc. 1998 Jul;30(7):1086-96.

PMID:
9662678
39.

The context of the Activity Counseling Trial.

Simons-Morton DG.

Med Sci Sports Exerc. 1998 Jul;30(7):1084-5. No abstract available.

PMID:
9662677
40.

Cardiovascular disease prevention research at the National Heart, Lung, and Blood Institute.

Simons-Morton DG, Cutler JA.

Am J Prev Med. 1998 May;14(4):317-30. No abstract available.

PMID:
9635078
41.

Dose-response relationship of physical activity and cardiovascular disease risk.

Simons-Morton DG.

J Am Geriatr Soc. 1998 Feb;46(2):238-40. No abstract available.

PMID:
9475456
42.

A meta-analysis of trials evaluating patient education and counseling for three groups of preventive health behaviors.

Mullen PD, Simons-Morton DG, Ramírez G, Frankowski RF, Green LW, Mains DA.

Patient Educ Couns. 1997 Nov;32(3):157-73.

PMID:
9423498
43.

Safety of a fat-reduced diet: the Dietary Intervention Study in Children (DISC).

Obarzanek E, Hunsberger SA, Van Horn L, Hartmuller VV, Barton BA, Stevens VJ, Kwiterovich PO, Franklin FA, Kimm SY, Lasser NL, Simons-Morton DG, Lauer RM.

Pediatrics. 1997 Jul;100(1):51-9.

PMID:
9200359
44.

Nutrient intake and blood pressure in the Dietary Intervention Study in Children.

Simons-Morton DG, Hunsberger SA, Van Horn L, Barton BA, Robson AM, McMahon RP, Muhonen LE, Kwiterovich PO, Lasser NL, Kimm SY, Greenlick MR.

Hypertension. 1997 Apr;29(4):930-6.

PMID:
9095079
45.

Diet and blood pressure in children and adolescents.

Simons-Morton DG, Obarzanek E.

Pediatr Nephrol. 1997 Apr;11(2):244-9. Review.

PMID:
9090675
46.

Smoking, smoking cessation, and understanding of the role of multiple cardiac risk factors among the urban poor.

Hyman DJ, Simons-Morton DG, Dunn JK, Ho K.

Prev Med. 1996 Nov-Dec;25(6):653-9.

PMID:
8936566
48.

Cholesterol-related knowledge, attitudes, and behaviors in a low-income, urban patient population.

Hyman DJ, Simons-Morton DG, Ho K, Dunn JK, Rubovits DS.

Am J Prev Med. 1993 Sep-Oct;9(5):282-9.

PMID:
8257617
49.

Hypertension treatment trials and stroke occurrence revisited. A quantitative overview.

Simons-Morton DG, Cutler JA, Allender PS.

Ann Epidemiol. 1993 Sep;3(5):555-62.

PMID:
8167837
50.

Characteristics of controlled studies of patient education and counseling for preventive health behaviors.

Simons-Morton DG, Mullen PD, Mains DA, Tabak ER, Green LW.

Patient Educ Couns. 1992 Apr;19(2):175-204. Review.

PMID:
1299821

Supplemental Content

Loading ...
Support Center